Obulytix logo

Obulytix

Pioneering a new class of targeted biologics called Precision Lysin Therapeutics (PLTs), as next-generation antibiotics. PLTs are proteins engineered to eliminate harmful bacteria associated with life-threatening infections in critically ill patients with precision and speed.

Headquarters

Belgium

Employees

11-50

Links


Org chart

Collapse
No reports!

Teams


Offices